This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]
| p/e | p/bv | ROE | dy | market cap |
net margin |
|
|---|---|---|---|---|---|---|
| 21.29 | 6.17 | 28.97% | 0.35% | $ 1.50 T | 32.84% | |
| 9.41 | 6.74 | 71.59% | 1.99% | $ 2.53 B | 9.10% | |
| 5.64 | 1.34 | 23.78% | 6.72% | $ 114.38 B | 21.75% | |
| 22.80 | 1.73 | 7.59% | 6.65% | $ 65.02 B | 7.21% | |
| 142.21 | 37.92 | 26.67% | 0.00% | $ 324.46 B | 43.67% | |
| 12.76 | 1.37 | 10.74% | 3.42% | $ 239.25 B | 7.01% | |
| 9.35 | 0.58 | 6.21% | 3.00% | $ 21.87 B | 8.65% | |
| 11.06 | 1.52 | 13.78% | 7.68% | $ 4.71 B | 81.08% | |
| 10.61 | 5.98 | 56.41% | 4.15% | $ 248.22 B | 10.91% | |
| 24.45 | 2.49 | 10.18% | 4.89% | $ 122.87 B | 10.01% | |
| 5.03 | 1.20 | 23.78% | 6.80% | $ 102.14 B | 21.75% | |
| 9.58 | 2.00 | 20.84% | 2.07% | $ 83.72 B | 12.12% | |
| 8.10 | 5.70 | 70.42% | 11.31% | $ 13.78 B | 100.00% | |
| 30.12 | 3.44 | 11.44% | 2.21% | $ 362.72 B | 2.68% | |
| 9.80 | 1.41 | 14.44% | 1.67% | $ 184.03 B | 27.40% | |
| 12.75 | 1.54 | 12.05% | 6.33% | $ 192.32 B | 8.20% | |
| 33.04 | 13.10 | 39.66% | 1.23% | $ 61.42 B | 22.18% | |
| 64.37 | 4.22 | 6.56% | 0.00% | $ 21.07 B | 100.00% | |
| 17.26 | 2.06 | 11.96% | 2.74% | $ 186.59 B | 23.39% |
Average Investor10 user rating
4.0
(1 people)
Founded:
Time since IPO - - year
Employees
Alzamend Neuro Inc (United States) is listed on the Nasdaq and has a market capitalization of $4.22 Millions, with shareholders equity totaling $2.18 Millions.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Alzamend Neuro Inc reported $- in revenue, generating net income of $-7.04 Millions.
Key financial metrics include a P/E ratio of -0.60, a price-to-book (P/B) ratio of 1.93, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ALZN.
Market cap
$ 4.22 Millions
$ 4.22 Millions
Net worth
$ 2.18 Millions
$ 2,184,505.00
Assets
$ 4.04 Millions
$ 4,041,833.00
Total Shares Outstanding
3.80 Millions
3,804,000
Average Daily Trading Volume
$ -
$ -
Sector
Others
Industry
Others
Shares
30.12
2.21%
11.44%
3.44
-1.01
0.00%
-32.04%
0.32
0.13
1.59%
20.55%
0.03
13.54
4.85%
1.69%
0.23
21.04
0.85%
71.09%
14.96
12.76
3.42%
10.74%
1.37
3.26
4.39%
14.34%
0.47
10.61
4.15%
56.41%
5.98
30.12
2.21%
11.44%
3.44
-1.01
0.00%
-32.04%
0.32
0.13
1.59%
20.55%
0.03
13.54
4.85%
1.69%
0.23
21.04
0.85%
71.09%
14.96
12.76
3.42%
10.74%
1.37
3.26
4.39%
14.34%
0.47
10.61
4.15%
56.41%
5.98
The current price of Alzamend Neuro Inc (ALZN) is $ 1.15, representing a -65.36% gain over the past year. The stock began the year trading around $ 1.82 and is currently priced at $ 1.15. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.
When does Alzamend Neuro Inc (ALZN) pay dividends?
Alzamend Neuro Inc (ALZN) did not pay dividends over the past year.
Alzamend Neuro Inc (ALZN) is currently trading at $ 1.15 with a P/E ratio of -0.60. This represents a -10,548% premium compared to its historical average P/E. Over the past year, the stock has gained -65.36 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -65.36%.
Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.
You can buy Alzamend Neuro Inc (ALZN) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ALZN and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.
Over the past month, Alzamend Neuro Inc (ALZN) has returned 9.52% — -65.36% over the past year, and -99.99% over the past five years, including price appreciation and dividends.
In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.
If you were to purchase 100 shares of Alzamend Neuro Inc (ALZN) today at the current price of $ 1.15 your total investment would be $ 115.00.
Based on historical performance, the investment would have grown to approximately:
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Register
Already have an account? Login
Register
Register for free to continue accessing Investor10.
Already have an account? Login
Tesla
Dividend Calendar
Stock Rankings
ETF Rankings
Crypto Rankings
